Suppliers / Chengda Pharmaceuticals

Chengda Pharmaceuticals

China 17 employees Updated 9 July 2026

Chengda Pharmaceuticals is a contract manufacturer based in China. It holds 8 active US drug master files and 2 valid CEPs across a filed portfolio of 6 molecules. Its GMP standing is certified by MFDS (Korea) and US FDA. Its most recent recorded inspection, by US FDA, closed on 15 November 2024 as NAI.

8
active US DMFs
2
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 15 November 2024 NAI US FDA
  • 25 March 2016 VAI US FDA
  • 15 March 2013 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Jiashan, China Not on file
China, China 3004248447

What they file, and where

Molecule Regulators Docs
Levocarnitine EDQM, SFDA (Saudi Arabia), US FDA 3
Acalabrutinib US FDA 2
Brivaracetam EDQM, US FDA 2
Venetoclax US FDA 2
Elagolix US FDA 1
Rivaroxaban US FDA 1

Also appears on these molecule pages

Levocarnitine contract manufacturing Levofloxacin contract manufacturing Linagliptin contract manufacturing Ofloxacin contract manufacturing Rivaroxaban contract manufacturing Sitagliptin contract manufacturing Vildagliptin contract manufacturing

Filings and GMP by regulator

Regulator Filings GMP certificates
MFDS (Korea) None 2
US FDA None 1

Comparing suppliers?

Choose your molecules and target markets. Chengda Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 15 November 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates